HB0034

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
37	膿疱性乾癬（汎発型）	1

37. 膿疱性乾癬（汎発型）

臨床試験数 : 79 / 薬物数 : 57 - (DrugBank : 21) / 標的遺伝子数 : 20 - 標的パスウェイ数 : 102

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05512598 (ClinicalTrials.gov)	November 6, 2022	22/8/2022	HB0034 in Patients With Generalized Pustular Psoriasis (GPP)	Multi-centre, Open-label, Single-arm, Phase Ib Study to Evaluate the Safety, Pharmacokinetics, and E ...	Generalized Pustular Psoriasis	Drug: HB0034	Shanghai Huaota Biopharmaceutical Co., Ltd.	NULL	Recruiting	18 Years	75 Years	All	10	Phase 1	China

First Previous1Next Last